Results 121 to 130 of about 125,716 (297)
Rap1 Activation Protects Against Fatty Liver and Non-Alcoholic Steatohepatitis Development [PDF]
Heena Agarwal, Yating Wang, Lale Özcan
openalex +1 more source
High-fat diets combined with the introduction of lincomycin causes the development of steatohepatitis. Introduction antidysbiotic drugs (pro- and prebiotics) has a therapeutic effect.
A. P. Levitsky +2 more
doaj
Gallic acid (GA), a natural organic phenolic compound, is an abundant plant food bioactive substance present in many medicinal herbs. GA has anti-oxidative, anti-inflammatory and anticancer activities on multiple metabolic disorders.
Jiahao Qiu +20 more
doaj +1 more source
Leptin and interleukin-6 level in patients with hypertension and obesity combined with non-alcoholic steatohepatitis during treatment with sartans and statins [PDF]
O. M. Bochar +2 more
openalex +1 more source
Roux-En Y Gastric Bypass Results in Long-Term Remission of Hepatocyte Apoptosis and Hepatic Histological Features of Non-alcoholic Steatohepatitis [PDF]
Anne-Sophie Schneck +11 more
openalex +1 more source
CAQ Corner: Basic concepts of transplant immunology
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley +1 more source
Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes [PDF]
Kenneth Cusi
openalex +1 more source
CAQ Corner: Immune‐mediated complications
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley +1 more source
Alcoholic liver disease: State-of-the-art
The literature review gives the present views of the diagnosis and treatment of alcoholic liver disease (ALD) and data on the genetic markers associated with the development of ALD and alcohol addiction.
I V Maev +3 more
doaj

